5 news items
Candel Therapeutics to Host Non-Small Cell Lung Cancer (NSCLC) R&D Breakfast Panel During 2024 ASCO Annual Meeting
CADL
20 May 24
announced it will be hosting a webcasted R&D breakfast panel featuring prominent scientific and medical thought leaders to discuss topline
Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb
AZN
CADL
HALO
9 May 24
Vice President, Oncology R&D, AstraZeneca. "The improvement in progression-free survival together
Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb
AZN
CADL
HALO
9 May 24
, Executive Vice President, Oncology R&D, AstraZeneca. "The improvement in progression-free survival
Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb
AZN
CADL
HALO
9 May 24
," said Susan Galbraith, Executive Vice President, Oncology R&D, AstraZeneca
Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb
AZN
CADL
HALO
9 May 24
survival," said Susan Galbraith, Executive Vice President, Oncology R&D, AstraZeneca
- Prev
- 1
- Next